Yonglin Pu

3PUBLICATIONS
7CO-AUTHORS
Tumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 21, 2021
Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma.

Jonathan A Trujillo, James Godfrey, Yifei Hu

|Jun 09, 2018
Developing and validating a novel metabolic tumor volume risk stratification system for supplementing non-small cell lung cancer staging.

Yonglin Pu, James X Zhang, Haiyan Liu

|May 22, 2018
Whole body metabolic tumor volume is a prognostic marker in patients with newly diagnosed stage 3B non-small cell lung cancer, confirmed with external validation.

Brittany Z Dashevsky, Chenpeng Zhang, Li Yan

Pageof 1

Frequent Collaborators

1 joint publications

Jonathan A Trujillo

1 joint publications

James Godfrey

1 joint publications

Yifei Hu

1 joint publications

Jun Huang